William Jones

William A. Jones is currently Director at LUNGevity Foundation since 2020, Director at Akili Interactive Labs, Inc. since 2022, Independent Director at Apogee Therapeutics, Inc. since 2023, Director at Annexon, Inc. starting 2025, and Chief Commercial Officer at NewAmsterdam Pharma Co. NV since 2023.
Formerly, Mr. Jones was Director-US Marketing at Bristol Myers Squibb Co. from 1992 to 2004, Vice President-Marketing & Business Development at NitroMed, Inc. from 2004 to 2007, Vice President-Sales at Boehringer Ingelheim Pharmaceuticals, Inc. from 2007 to 2013, Vice President & Head-Sales at AstraZeneca Pharmaceuticals LP from 2014 to 2016, VP, Head-Sales & Commercial Operations at Takeda Pharmaceuticals U.S.A., Inc. from 2016 to 2019, Chief Commercial Officer-Migraine & Common Disease at Biohaven Pharmaceutical Holding Co. Ltd. from 2019 to 2022, and Independent Director at Akili, Inc. from 2022 to 2024.
Education includes graduate studies at Texas A&M University, undergraduate studies at United States Air Force Academy, and an MBA from Stanford Graduate School of Business.